Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Morning Overview on MSN
Revolution Medicines trial points to longer survival in pancreatic cancer
For more than two decades, oncologists treating advanced pancreatic cancer have watched new drugs fail to move the survival ...
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...
Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune ...
A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be ...
The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...
"The number one thing I tell care partners is that they’re going to have emotions and it’s okay to feel sad. It’s okay to be ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results